Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma

Journal of Clinical Oncology

Volumn 19, Issue 16, 2001, Pages 3660-3668

  Chia, S K ^a   Wykoff, C C ^a   Watson, P H ^a   Han, C ^a   Leek, R D ^a   Pastorek, J ^a   Gatter, K C ^a   Ratcliffe, P ^a   Harris, A L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035881075     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.16.3660     Document Type: Article

References (46)

1. Polychemotherapy for early breast cancer
2. Tamoxifen for early breast cancer: An overview of the randomized trials
3. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update
4. Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis
5. Breast cancer: Relationship between the size of the primary tumor and the probability of metastatic dissemination
6. Steroid receptors and other prognostic factors in primary breast cancer
7. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
8. Oxygenation predicts radiation response and survival in patients with cervix cancer
9. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
10. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06: 10 Year pathologic and clinical prognostic discriminants
11. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast
12. Clinicopathologic study of angiogenesis in Japanese patients with breast cancer
13. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
14. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer
15. Tumor angiogenesis in node-negative breast carcinomas: Relationship with epidermal growth factor receptor and survival
16. Tumor microvessel density, p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
17. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
18. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment
19. Hypoxia inducible expression of tumor associated carbonic anhydrases
20. Carbonic anhydrase: Chemistry, physiology and inhibition
21. The carbonic anhydrases: Widening perspectives on their evolution, expression and function
22. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens
23. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment
24. Human MN/CA 9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships
25. Functional diversity, conservation, and convergence in the evolution of the alpha-, beta- and gamma-carbonic anhydrase gene families
26. Carbonic anhydrase IX, MN/CA IX: Analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts
27. Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity
28. Identification of the MN/CA 9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney
29. Expression of the tumor-associated gene MN: A potential biomarker for human renal cell carcinoma
30. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: A clinicopathological study of a new cancer associated biomarker
31. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma
32. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation
33. Expression of the hypoxia inducible and tumor associated carbonic anhydrases in ductal carcinoma in situ (DCIS) of the breast
34. The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients
35. Pathological prognostic factors in breast cancer: The value of histological grade in breast cancer - Experience from a large study with long term follow-up
36. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
37. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN
38. The relevance of tumour pH to the treatment of malignant disease
39. Cellular pH gradient in tumor versus normal tissue: Potential exploitation for the treatment of cancer
40. Are cancer cell acidic?
41. Studies of human tumours by MRS: A review
42. Enhancement of chemotherapy by manipulation of tumour pH
43. Down regulation of transmembrane carbonic anhydrases in renal carcinoma cell lines by wild-type von Hippel-Lindau transgenes
44. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA 9
45. Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250
46. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal cell carcinoma xenografts